Sequans and AmericanPharma Technologies Team Up to Protect Covid-19 Vaccine Shipments
May 12 2021 - 8:00AM
Business Wire
Sequans Communications S.A. (NYSE: SQNS) has joined forces with
AmericanPharma Technologies and is providing the cellular IoT
connectivity solution for AmericanPharma Tech’s PharmaWatch™
vaccine monitoring system that is currently protecting Covid-19
vaccine shipments and storage around the country. PharmaWatch is
connected by Sequans’ Monarch technology, enabling it to upload its
vaccine temperature monitoring data to the portal every 5 minutes
via a secure and reliable cellular LTE-M network transmission.
“PharmaWatch provides one of the most important IoT monitoring
solutions active in the world today and we are proud that our
Monarch LTE-M technology is providing the network connectivity,”
said Didier Dutronc, EVP and GM, Massive IoT, Sequans. “PharmaWatch
monitors vaccine temperature and other data and automates
compliance reporting, and our Monarch module gives PharmaWatch the
reliable, always-on network connection it needs to enable this
critically important IoT application.”
“We chose Sequans’ Monarch to connect PharmaWatch because it
allowed us to meet the exacting, real-time reporting requirements
necessary to ensure the efficacy of the vaccine, whether in
transport or in storage,” said Nick Ioli, COO, AmericanPharma Tech.
“Sequans’ Monarch is an extremely mature LTE-M platform, optimized
for IoT, and it gives our PharmaWatch customers exactly what they
need to meet the compliance regulations set by the CDC and other
governing bodies.”
PharmaWatch monitors temperatures as low as minus 200 degrees
Celsius and provides reporting data every 5 minutes, exceeding the
safety requirements of the CDC for the transport, storage, and
handling of Covid-19 vaccines. PharmaWatch comes with sensors
preconfigured for the required temperature ranges and can be
self-installed in minutes. Its patented Virtual Temperature
Buffering technology minimizes false alerts.
The connection to the cellular network is provided by Sequans
Monarch GM01Q module, one of the most mature and proven
LTE-M/NB-IoT connectivity solutions in the industry. Monarch is
designed and optimized for IoT, delivering ultra-low power
consumption and global deployment capability, making it an ideal
solution for IoT applications including sensors, meters and
trackers. The module includes an LTE-optimized transceiver and a
complete Single-SKU™ RF front end, supporting global deployment.
Monarch is certified by major operators all over the world.
About AmericanPharma
AmericanPharma Technologies was founded in 2010 when three
predecessor companies merged. Today, its core product is
PharmaWatch, the world's most advanced and complete environmental
monitoring system. It alleviates the difficulties inherent in
manually monitoring multiple healthcare environments in multiple
locations while automatically maintaining complete regulatory
compliance. PharmaWatch makes worry-free compliance, unparalleled
patient safety, and complete customer satisfaction an affordable
reality for the first time ever.
https://www.pharmawatch.com/pharmawatch/
About Sequans
Sequans Communications S.A. (NYSE: SQNS) is a leading developer
and provider of 5G and 4G chips and modules for massive, broadband,
and critical IoT. For 5G/4G massive IoT applications, Sequans
provides a comprehensive product portfolio based on its flagship
Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring
industry-leading low power consumption, a large set of integrated
functionalities, and global deployment capability. For 5G/4G
broadband and critical IoT applications, Sequans offers a product
portfolio based on its Cassiopeia Cat 4/Cat 6 4G and high-end
Taurus 5G chip platforms, optimized for low-cost residential,
enterprise, and industrial applications. Founded in 2003, Sequans
is based in Paris, France with additional offices in the United
States, United Kingdom, Finland, Israel, Hong Kong, Singapore,
Taiwan, South Korea, and China. Visit Sequans online at
www.sequans.com.
Forward Looking Statements
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210512005117/en/
Sequans media relations: Kimberly Tassin (USA), +1.425.736.0569,
kimberly@sequans.com Investor Relations: Kim Rogers, Hayden IR, +1
385.831.7337, Kim@haydenir.com
Sequans Communications (NYSE:SQNS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sequans Communications (NYSE:SQNS)
Historical Stock Chart
From Apr 2023 to Apr 2024